Snake venom evolved for prey not protection

It is estimated that every year, over 100,000 human deaths can be attributed to snakebite from the world’s 700 venomous snake species — all inflicted in self-defence when the snakes feel threatened by encroaching humans. However, a new piece of research concludes that snake venom did not evolve as a defence mechanism. Senior Lecturer Dr…

Details

Female lifespan is longer in wild mammal animals than in humans

On average, women live longer than men: About 90% of people reaching 110 years old or more are women. The current record holder is Jeanne Calment, who was 122 years old, when she died in 1997. Now a new study shows, that even greater differences in lifespan are found in wild mammals. The average female…

Details

Low risk of coronavirus spreading through tears

SAN FRANCISCO, Calif. — March 25, 2020 — While researchers are certain that coronavirus spreads through mucus and droplets expelled by coughing or sneezing, it is unclear if the virus is spread through other bodily fluids, such as tears. Today’s just-published study offers evidence that it is unlikely that infected patients are shedding virus through…

Details

Scripps Research launches DETECT study, leveraging wearable data to flag viral illnesses

LA JOLLA, CA — The Scripps Research Translational Institute has launched an app-based research program that will analyze participants’ wearable health data—including heart rates, sleep and activity levels—to more quickly detect the emergence of influenza, coronavirus and other fast-spreading viral illnesses. Members of the public who are 18 or older and use a smartwatch or…

Details

Culturally adapted materials boost Latino participation in diabetes education programs

CORVALLIS, Ore. — An Oregon State University study published last week found that diabetes education programs that are linguistically and culturally tailored to Latinos lead to significantly higher rates of completion among Latino participants — even higher than rates among non-Latinos enrolled in the English versions of those programs. Cultural adaptation means that a program…

Details

Trastuzumab deruxtecan shows early promise in patients with non-breast/gastric cancers

Bottom Line: A HER2-targeted antibody-drug conjugate, fam-trastuzumab deruxtecan-nxki (Enhertu), showed signs of clinical activity in multiple non-breast/non-gastric cancer types, according to results from a phase I study. Journal in Which the Study was Published: Cancer Discovery, a journal of the American Association for Cancer Research Author: Lead author: Junji Tsurutani, MD, PhD, medical oncologist at…

Details